OQROGet OQRO Pro
Insider trade

Danaher Corporation (DHR)Chair sold ~$11.5M

Steven M Rales, Chair at Danaher Corporation, sold ~$11.5M of Danaher Corporation shares.

~$11.5M
Approx. value · 58K sh @ $197.86
3.48M
Holds after · shares reported
Traded
May 12, 2025
Filed
May 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 8, 2015CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  2. Feb 25, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  3. Mar 4, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  4. Mar 27, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  5. Apr 7, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  6. Apr 8, 2025CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  7. Apr 11, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  8. Apr 21, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  9. Apr 30, 2025Insider · 1 personInsiders: 2 sales (~$3.1M)
  10. May 12, 2025 · this disclosureInsiderChair sold ~$11.5M of DHR shares in the open market

What came next

  1. May 12, 2025Insider · 1 personInsiders: 7 sales (~$234.4M)
  2. May 12, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  3. May 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  4. Jun 11, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  5. Jun 12, 2025CongressDisclosed sale of DHR — reported range $50,001 - $100,000
  6. Jul 18, 2025FDAFDA device clearance: MicroScan Dried Gram-Negative MIC/Combo Panels with Aztreonam (AZT) (0.5-64 µg/mL)
  7. Jul 22, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  8. Jul 24, 2025FDARecall: MicroScan Neg MIC 56 REF C42464 UDI-DI code: 15099590731212 MicroScan panels are designed for use in determining antimicrobial agent susceptibility and/or iden…
  9. Aug 1, 2025FDAFDA device clearance: Access hsTnI
  10. Aug 4, 2025FDARecall: DxC 500 AU Module w/ISE, DxC 500i, With ISE, REF: C63522 and DxC 500 AU Module, DxC 500i, Without ISE, REF: C6352; part of the DxC 500i Clinical Analyzer
  11. Aug 6, 2025FDARecall: Xpert SA Nasal Complete Catalog Number: GXSACOMP-10 UDI-DI code: 07332940000158 Xpert SA Nasal Complete kit; 10 test kit: A collection of reagents and other as…
  12. Aug 13, 2025FDARecall: UniCel DxH 800 COULTER Cellular Analysis System, configured with the Led HGB Photometer REFs:B24802, 629029, B63322
  13. Aug 13, 2025FDARecall: UniCel DxH 900 COULTER Cellular Analysis System, configured with the Led HGB Photometer REF: C11478
  14. Aug 13, 2025FDARecall: UniCel DxH 690T COULTER Cellular Analysis System, configured with the Led HGB Photometer REF: C34520
  15. Aug 13, 2025FDARecall: UniCel DxH 600 COULTER Cellular Analysis System, configured with the Led HGB Photometer REF:B23858
  16. Aug 15, 2025FDAFDA device clearance: MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)
  17. Aug 20, 2025FDAFDA device clearance: MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan)
  18. Aug 22, 2025InsiderDirector sold ~$586K of DHR shares in the open market
  19. Aug 28, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  20. Sep 3, 2025FDARecall: SYNCHRON Systems Phosphorus (PHOSm) Reagent REF: 467868 For In Vitro Diagnostic Use, Rx Only.
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 86 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Steven M Rales, Chairman

The full history of Steven M Rales, Chairman is on the profile page.

How this filing works

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data